Oral COVID-19 Antiviral Uptake Among a Highly Vaccinated US Cohort of Adults With SARS-CoV-2 Infection Between December 2021 and October 2022

Access publication

Citation: Yanhan Shen, McKaylee M Robertson, Sarah G Kulkarni, Laura Puzniak, Joann M Zamparo, Kristen E Allen, Thomas M Porter, Saba A Qasmieh, Christian Grov, Avantika Srivastava, Rebecca Zimba, John M McLaughlin, and Denis Nash Oral COVID-19 Antiviral Uptake Among a Highly Vaccinated US Cohort of Adults With SARS-CoV-2 Infection Between December 2021 and October 2022 Shen Y, Robertson MM, Kulkarni SG, Puzniak L, Zamparo JM, Allen KE, Porter TM, Qasmieh SA, Grov C, Srivastava A, Zimba R, McLaughlin JM, Nash D. Oral COVID-19 Antiviral Uptake Among a Highly Vaccinated US Cohort of Adults With SARS-CoV-2 Infection Between December 2021 and October 2022. Open Forum Infect Dis. 2023 Dec 21;11(2):ofad674. doi: 10.1093/ofid/ofad674. PMID: 38344131; PMCID: PMC10854389.

Authors